"use strict";(self.webpackChunkgenomics_docusaurus_new=self.webpackChunkgenomics_docusaurus_new||[]).push([[736],{8453:(e,n,s)=>{s.d(n,{R:()=>o,x:()=>l});var i=s(6540);const r={},t=i.createContext(r);function o(e){const n=i.useContext(t);return i.useMemo((function(){return"function"==typeof e?e(n):{...n,...e}}),[n,e])}function l(e){let n;return n=e.disableParentContext?"function"==typeof e.components?e.components(r):e.components||r:o(e.components),i.createElement(t.Provider,{value:n},e.children)}},9621:(e,n,s)=>{s.r(n),s.d(n,{assets:()=>c,contentTitle:()=>l,default:()=>h,frontMatter:()=>o,metadata:()=>i,toc:()=>d});const i=JSON.parse('{"id":"mimic-onco/case_study","title":"Case Study","description":"Lung Cancer Progression and Outcomes","source":"@site/docs/mimic-onco/case_study.md","sourceDirName":"mimic-onco","slug":"/mimic-onco/case_study","permalink":"/datasolutions/mimic-onco/case_study","draft":false,"unlisted":false,"tags":[],"version":"current","sidebarPosition":2,"frontMatter":{"title":"Case Study","sidebar_position":2,"hide_title":true},"sidebar":"docsSidebar","previous":{"title":"Overview","permalink":"/datasolutions/mimic-onco/"}}');var r=s(4848),t=s(8453);const o={title:"Case Study",sidebar_position:2,hide_title:!0},l=void 0,c={},d=[{value:"Lung Cancer Progression and Outcomes",id:"lung-cancer-progression-and-outcomes",level:2},{value:"Pipeline Overview",id:"pipeline-overview",level:2},{value:"Ongoing Extensions (Exploratory)",id:"ongoing-extensions-exploratory",level:2},{value:"Diagram",id:"diagram",level:2}];function a(e){const n={a:"a",br:"br",code:"code",em:"em",h2:"h2",hr:"hr",li:"li",p:"p",pre:"pre",strong:"strong",ul:"ul",...(0,t.R)(),...e.components},{Details:s}=n;return s||function(e,n){throw new Error("Expected "+(n?"component":"object")+" `"+e+"` to be defined: you likely forgot to import, pass, or provide it.")}("Details",!0),(0,r.jsxs)(r.Fragment,{children:[(0,r.jsx)(n.h2,{id:"lung-cancer-progression-and-outcomes",children:"Lung Cancer Progression and Outcomes"}),"\n",(0,r.jsx)(n.hr,{}),"\n",(0,r.jsxs)("div",{style:{textAlign:"justify"},children:[(0,r.jsxs)(n.p,{children:["This case study presents an ",(0,r.jsx)(n.strong,{children:"exploratory, end-to-end oncology analysis pipeline"})," focused on modelling ",(0,r.jsx)(n.strong,{children:"disease progression and outcomes in lung cancer patients"})," using real-world clinical data."]}),(0,r.jsxs)(n.p,{children:["It combines ",(0,r.jsx)(n.strong,{children:"structured EHR data"})," (laboratory values, medications, demographics) with ",(0,r.jsx)(n.strong,{children:"AI-extracted clinical signals"})," from free-text notes to derive ",(0,r.jsx)(n.strong,{children:"progression-free survival (PFS)"})," metrics and prototype survival models.",(0,r.jsx)(n.br,{}),"\n","The emphasis is methodological: demonstrating how heterogeneous clinical data sources can be integrated into reproducible oncology analytics."]}),(0,r.jsx)("em",{children:(0,r.jsx)(n.p,{children:"Note: Due to the limited size and heterogeneity of oncology patients in MIMIC-IV, this case study is not intended to support definitive clinical inference. It serves as a methodological demonstration of clinical NLP integration and survival-analysis workflows."})}),(0,r.jsx)("br",{}),(0,r.jsxs)(s,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)("strong",{children:"1 \xb7 Build the lung cancer cohort"})}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Objective:"})," Identify patients with a primary lung cancer diagnosis and define a reproducible start point for follow-up."]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Method:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:["Selected admissions with ICD-10 codes ",(0,r.jsx)(n.strong,{children:"C34*"})," or ICD-9 codes ",(0,r.jsx)(n.strong,{children:"162*"})," (malignant neoplasm of the lung)"]}),"\n",(0,r.jsxs)(n.li,{children:["Defined the ",(0,r.jsx)(n.strong,{children:"first qualifying hospital encounter"})," as the index date"]}),"\n"]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Output:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:(0,r.jsx)(n.code,{children:"lung_cancer_cohort.csv"})})," \u2014 one row per patient (",(0,r.jsx)(n.em,{children:"4 220 patients"}),")"]}),"\n"]})]}),(0,r.jsxs)(s,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)("strong",{children:"2 \xb7 Extract progression / response events"})}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Objective:"})," Identify the earliest documented evidence of ",(0,r.jsx)(n.strong,{children:"disease progression"})," or ",(0,r.jsx)(n.strong,{children:"treatment response"}),"."]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Method:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:["Applied fine-tuned ",(0,r.jsx)(n.strong,{children:"clinical NLP models"})," to radiology reports and discharge summaries",(0,r.jsx)(n.br,{}),"\n","(",(0,r.jsx)(n.a,{href:"https://physionet.org/content/dfci-cancer-outcomes-ehr/1.0.0/",children:"Kehl et al., 2024"}),")"]}),"\n",(0,r.jsxs)(n.li,{children:["Models output per-note probabilities for ",(0,r.jsx)(n.strong,{children:"progression"}),", ",(0,r.jsx)(n.strong,{children:"response"}),", and ",(0,r.jsx)(n.strong,{children:"metastatic involvement"}),(0,r.jsx)(n.br,{}),"\n","(brain, bone, liver, adrenal, lung, lymph nodes, peritoneum)"]}),"\n",(0,r.jsxs)(n.li,{children:["Flagged the ",(0,r.jsx)(n.strong,{children:"earliest note"})," exceeding a probability threshold of \u2265 0.50"]}),"\n"]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Outputs:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsx)(n.li,{children:(0,r.jsx)(n.strong,{children:(0,r.jsx)(n.code,{children:"mimic_lung_radiology_preds.csv"})})}),"\n",(0,r.jsx)(n.li,{children:(0,r.jsx)(n.strong,{children:(0,r.jsx)(n.code,{children:"mimic_lung_discharge_preds.csv"})})}),"\n"]})]}),(0,r.jsxs)(s,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)("strong",{children:"3 \xb7 Derive progression-free survival (PFS)"})}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Objective:"})," Quantify time from diagnosis to first documented progression or response."]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Method:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Start:"})," index date"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Event:"})," earliest progression or response signal"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Censoring:"})," date of last available clinical note"]}),"\n",(0,r.jsxs)(n.li,{children:["Computed ",(0,r.jsx)(n.strong,{children:"PFS in days"})," per patient"]}),"\n"]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Output:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:(0,r.jsx)(n.code,{children:"lung_events.csv"})})," \u2014 event dates and PFS durations"]}),"\n"]})]}),(0,r.jsxs)(s,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)("strong",{children:"4 \xb7 Generate baseline features"})}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Objective:"})," Capture baseline patient characteristics relevant for exploratory risk modelling."]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Method:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Demographics:"})," age and sex"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Biomarkers:"})," first LDH measurement within \xb17 days of index date"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Treatment exposure:"})," flags for platinum chemotherapy, TKIs, and checkpoint inhibitors",(0,r.jsx)(n.br,{}),"\n","(regex-based drug mapping)"]}),"\n"]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Output:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:(0,r.jsx)(n.code,{children:"lung_baseline.csv"})})," \u2014 baseline features per patient"]}),"\n"]})]}),(0,r.jsxs)(s,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)("strong",{children:"5 \xb7 Merge & analyse"})}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Objective:"})," Assemble a unified analytic dataset and perform exploratory survival analysis."]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Method:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsx)(n.li,{children:"Merged cohort, event, and baseline feature tables"}),"\n",(0,r.jsxs)(n.li,{children:["Generated ",(0,r.jsx)(n.strong,{children:"Kaplan\u2013Meier curves"})," (overall and stratified by treatment class)"]}),"\n",(0,r.jsxs)(n.li,{children:["Fit a ",(0,r.jsx)(n.strong,{children:"Cox proportional-hazards model"})," using age, sex, LDH, and treatment flags"]}),"\n"]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Output:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:(0,r.jsx)(n.code,{children:"lung_pfs.csv"})})," \u2014 final analytic table (",(0,r.jsx)(n.em,{children:"3 204 patients with follow-up"}),")"]}),"\n"]})]})]}),"\n",(0,r.jsx)(n.hr,{}),"\n",(0,r.jsx)(n.h2,{id:"pipeline-overview",children:"Pipeline Overview"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{className:"language-text",children:"SQL cohort \u2500\u2510\n            \u251c\u2500\u2500\u25ba 1  Export lung_radiology.csv  \u2500\u2500\u25ba 2  NLP inference (DFCI-imaging) \u2500\u2510\n            \u251c\u2500\u2500\u25ba 1  Export lung_discharge.csv  \u2500\u2500\u25ba 2  NLP inference (DFCI-medonc)  \u2500\u2524\n            \u2502                                                                       \u2502\n            \u2514\u2500\u2500\u25ba 3  Baseline extract (age/sex/LDH) \u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2524\n                                                                                   \u25bc\n                                         4  Derive events  \u2500\u2500\u25ba lung_events.csv\n                                         5  Drug-class flags \u2500\u25ba lung_drug_flags.csv\n                                         6  Merge            \u2500\u25ba lung_pfs.csv\n                                         7  KM + Cox plots   \u2500\u25ba notebook / report\n"})}),"\n",(0,r.jsx)(n.hr,{}),"\n",(0,r.jsx)(n.h2,{id:"ongoing-extensions-exploratory",children:"Ongoing Extensions (Exploratory)"}),"\n",(0,r.jsx)(n.hr,{}),"\n",(0,r.jsxs)("div",{style:{textAlign:"justify"},children:[(0,r.jsxs)(s,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)("strong",{children:"6 \xb7 Toward automated cancer staging"})}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Goal:"}),(0,r.jsx)(n.br,{}),"\n","Approximate disease stage using site-specific metastasis predictions extracted from radiology notes."]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Approach:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsx)(n.li,{children:"Aggregated metastasis probabilities (brain, bone, liver, adrenal, lung, lymph nodes, peritoneum) into a composite \u201cextent of disease\u201d score"}),"\n",(0,r.jsx)(n.li,{children:"Mapped these signals to simplified staging categories (e.g. localised vs metastatic)"}),"\n"]}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Rationale:"}),(0,r.jsx)(n.br,{}),"\n","Bridges raw NLP-derived outputs with clinically interpretable staging proxies."]})]}),(0,r.jsxs)(s,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)("strong",{children:"7 \xb7 Predicting early progression"})}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Goal:"}),(0,r.jsx)(n.br,{}),"\n","Identify patients likely to experience disease progression within ",(0,r.jsx)(n.strong,{children:"90\u2013180 days"})," of the index date."]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Approach:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsx)(n.li,{children:"Features: demographics, baseline LDH, treatment flags, and aggregated NLP outputs"}),"\n",(0,r.jsx)(n.li,{children:"Models: XGBoost and regularised logistic regression"}),"\n"]}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Rationale:"}),(0,r.jsx)(n.br,{}),"\n","Explores feasibility of early risk stratification and supports hypothesis generation for clinical trial matching."]})]}),(0,r.jsxs)(s,{children:[(0,r.jsx)("summary",{children:(0,r.jsx)("strong",{children:"8 \xb7 Exploratory patient embeddings"})}),(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Goal:"}),(0,r.jsx)(n.br,{}),"\n","Represent patients in a latent clinical space to uncover similarity patterns across disease trajectories."]}),(0,r.jsx)(n.p,{children:(0,r.jsx)(n.strong,{children:"Approach:"})}),(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsx)(n.li,{children:"Embedded laboratory values, treatment exposure, and NLP-derived clinical signals into a low-dimensional representation"}),"\n",(0,r.jsx)(n.li,{children:"Visualised patient clusters associated with progression dynamics and therapeutic exposure"}),"\n"]})]})]}),"\n",(0,r.jsx)(n.hr,{}),"\n",(0,r.jsx)(n.h2,{id:"diagram",children:"Diagram"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{className:"language-text",children:"        \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510\n        \u2502   Core Pipeline Output      \u2502\n        \u2502    (lung_pfs.csv)           \u2502\n        \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u252c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\n                      \u2502\n   \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u253c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510\n   \u2502                  \u2502                  \u2502\n   \u25bc                  \u25bc                  \u25bc\n\u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510  \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510   \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510\n\u2502  Automated    \u2502  \u2502  Early Progression  \u2502   \u2502  Patient Embeddings \u2502\n\u2502   Staging     \u2502  \u2502   Prediction        \u2502   \u2502 (Clinical Similarity\u2502\n\u2502 (metastasis \u2192 \u2502  \u2502 (XGBoost / Logistic \u2502   \u2502   & Phenotyping)    \u2502\n\u2502   stage)      \u2502  \u2502  Regression)        \u2502   \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\n\u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518  \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\n"})})]})}function h(e={}){const{wrapper:n}={...(0,t.R)(),...e.components};return n?(0,r.jsx)(n,{...e,children:(0,r.jsx)(a,{...e})}):a(e)}}}]);